Main Page

Revision as of 05:21, 4 March 2013 by S (Talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

TBI: Theragen BiO institute

TBI (Theragen BiO Institute) is the Genome Business Division of Theragen Inc. Korea.

It is headed by Dr. Jong Bhak, CEO of TBI (The genomics division of TheragenEtex Inc.): jong.theragen@gmail.com

TBI News
►TBI has a San Diego office (from 2013 Jan.) ►TBI's the first freely available public female human genome sequence FTP site ►TBI's first Korean Human Genome service FTP site ►Theragen sponsors GETconference.org ►Theragen Launched the first commercial Genome Sequencing Service ►Theragen researchers participated in PanAsia SNP project to map the genetic diversity of Asians ►Theragen researchers analyzed the first Korean genome in 2008
Research: TBI is genomics/bioinformatics center
Personalized Medicine Personal Genomics AngioGenesis drug Bioinformatics RNA expression Protein structure
Projects at TBI
♦ GenomeCare: TBI aims to link genes to diseases ♦ Korean Genome: The first Korean genome was analyzed by Theragen scientists. ♦ Asian Genome Diversity: PASNP ♦ Family Genome Sequencing: Theragen is working with LCDI and Samsung SDS to sequence 2 family genomes. ♦ Molecular Diagnosis